PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAnakinra
Kineret(anakinra)
Kineret (anakinra) is a protein pharmaceutical. Anakinra was first approved as Kineret on 2001-11-14. It is used to treat cryopyrin-associated periodic syndromes and rheumatoid arthritis in the USA. It has been approved in Europe to treat rheumatoid arthritis.
Download report
Favorite
COVID-19
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
musculoskeletal diseasesD009140
hereditary congenital and neonatal diseases and abnormalitiesD009358
skin and connective tissue diseasesD017437
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Kineret
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Anakinra
Tradename
Proper name
Company
Number
Date
Products
KineretanakinraOrphan MedicalN-103950 RX2001-11-14
1 products
Labels
FDA
EMA
Brand Name
Status
Last Update
kineretBiologic Licensing Application2024-09-20
Agency Specific
FDA
EMA
Expiration
Code
anakinra, Kineret, Swedish Orphan Biovitrum AB (publ)
2027-12-18Orphan excl.
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
L04: Immunosuppressants
L04A: Immunosuppressants
L04AC: Interleukin inhibitors
L04AC03: Anakinra
HCPCS
No data
Clinical
Clinical Trials
204 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ArthritisD001168EFO_0005856M05-M14623717
Rheumatoid arthritisD001172EFO_0000685M06.9313714
Diabetes mellitusD003920EFO_0000400E08-E1328119
Type 2 diabetes mellitusD003924EFO_0001360E113137
Mucocutaneous lymph node syndromeD009080EFO_0004246M30.3221116
SepsisD018805EFO_0001420A41.932116
RecurrenceD01200812115
PericarditisD010493EFO_0007427I3011125
Hereditary autoinflammatory diseasesD056660213
Familial mediterranean feverD010505M04.1213
Show 6 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.955
Multiple myelomaD009101C90.0245
Plasma cell neoplasmsD054219245
Acute lung injuryD055371EFO_0004610134
Newborn respiratory distress syndromeD012127P22134
B-cell lymphomaD01639344
AsthmaD001249EFO_0000270J453314
Macrophage activation syndromeD055501EFO_1001806134
Chronic kidney failureD007676EFO_0003884N18.6314
Neurotoxicity syndromesD020258G92133
Show 93 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R52123
Healthy volunteers/patients33
Pulmonary arterial hypertensionD000081029112
NeoplasmsD009369C8022
Smoldering multiple myelomaD00007512211
B-cell chronic lymphocytic leukemiaD015451C91.111
Prostatic neoplasmsD011471C6111
Castration-resistant prostatic neoplasmsD06412911
GranulomaD00609911
Chronic granulomatous diseaseD006105EFO_0000338D7111
Show 11 more
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameAnakinra
INNanakinra
Description
Interleukin-1 receptor antagonist protein precursor (IL-1ra) (IRAP)
Classification
Protein
Drug classinterleukin receptor antagonists: interleukin-1 (IL-1) receptor antagonists
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL1201570
ChEBI ID
PubChem CID
DrugBankDB00026
UNII ID9013DUQ28K (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Anakinra
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 16,749 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
12,878 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use